Nektar Therapeutics
NKTR
#4848
Rank
A$2.69 B
Marketcap
A$96.40
Share price
-7.06%
Change (1 day)
379.19%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$62.6 Million. In 2024 the company made an earning of -A$0.17 Billion, an increase over its 2023 earnings that were of -A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion4.74%
2024 -A$0.17 Billion-56.85%
2023 -A$0.39 Billion-24.31%
2022 -A$0.52 Billion-30.25%
2021 -A$0.74 Billion17.87%
2020 -A$0.63 Billion0.88%
2019 -A$0.62 Billion-164.46%
2018 A$0.96 B-810.61%
2017 -A$0.14 Billion-37.06%
2016 -A$0.22 Billion89.22%
2015 -A$0.12 Billion48.22%
2014 -A$76.69 Million-65.93%
2013 -A$0.23 Billion-6.81%
2012 -A$0.25 Billion28.95%
2011 -A$0.19 Billion258.8%
2010 -A$52.21 Million-63.94%
2009 -A$0.15 Billion-392.45%
2008 A$49.51 M-211.74%
2007 -A$44.32 Million-79.57%
2006 -A$0.22 Billion-16.9%
2005 -A$0.27 Billion81.53%
2004 -A$0.15 Billion54.19%
2003 -A$93.25 Million-33.87%
2002 -A$0.15 Billion-9.6%
2001 -A$0.16 Billion73.39%
2000 -A$89.96 Million108.9%
1999 -A$43.07 Million39.48%
1998 -A$30.88 Million60.02%
1997 -A$19.3 Million18.05%
1996 -A$16.35 Million31.82%
1995 -A$12.4 Million57.14%
1994 -A$7.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.64 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.69 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.61 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.39 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.53 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.44 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$1.42 M-100.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.57 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland